Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands |
Total |
Total Stockholders' Equity |
Common Stock |
Additional Paid In Capital |
Distributions in Excess of Cumulative Earnings |
Accumulated Other Comprehensive (Loss) Income |
Non-controlling Interests |
Beginning balance (in shares) at Dec. 31, 2023 |
|
|
164,635,150
|
|
|
|
|
Beginning balance at Dec. 31, 2023 |
$ 2,987,002
|
$ 2,978,579
|
$ 1,646
|
$ 3,078,459
|
$ (105,545)
|
$ 4,019
|
$ 8,423
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
Common stock issuance (in shares) |
|
|
10,508,096
|
|
|
|
|
Common stock issuance |
244,735
|
244,735
|
$ 105
|
244,630
|
|
|
|
Common stock withheld related to net share settlement of equity awards |
(3,277)
|
(3,277)
|
|
|
(3,277)
|
|
|
Costs related to issuance of common stock |
(366)
|
(366)
|
|
(366)
|
|
|
|
Other comprehensive income (loss) |
19,631
|
19,575
|
|
|
|
19,575
|
56
|
Equity based compensation expense (in shares) |
|
|
163,140
|
|
|
|
|
Equity-based compensation expense |
2,947
|
2,947
|
$ 2
|
2,945
|
|
|
|
Dividends declared on common stock and OP Units |
(50,236)
|
(50,079)
|
|
|
(50,079)
|
|
(157)
|
Net income |
47,123
|
46,975
|
|
|
46,975
|
|
148
|
Ending balance (in shares) at Mar. 31, 2024 |
|
|
175,306,386
|
|
|
|
|
Ending balance at Mar. 31, 2024 |
3,247,559
|
3,239,089
|
$ 1,753
|
3,325,668
|
(111,926)
|
23,594
|
8,470
|
Beginning balance (in shares) at Dec. 31, 2023 |
|
|
164,635,150
|
|
|
|
|
Beginning balance at Dec. 31, 2023 |
2,987,002
|
2,978,579
|
$ 1,646
|
3,078,459
|
(105,545)
|
4,019
|
8,423
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
Other comprehensive income (loss) |
21,379
|
|
|
|
|
|
|
Net income |
98,798
|
|
|
|
|
|
|
Ending balance (in shares) at Jun. 30, 2024 |
|
|
175,330,314
|
|
|
|
|
Ending balance at Jun. 30, 2024 |
3,252,271
|
3,243,798
|
$ 1,753
|
3,328,082
|
(111,373)
|
25,336
|
8,473
|
Beginning balance (in shares) at Mar. 31, 2024 |
|
|
175,306,386
|
|
|
|
|
Beginning balance at Mar. 31, 2024 |
3,247,559
|
3,239,089
|
$ 1,753
|
3,325,668
|
(111,926)
|
23,594
|
8,470
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
Common stock issuance (in shares) |
|
|
23,928
|
|
|
|
|
Costs related to issuance of common stock |
(228)
|
(228)
|
|
(228)
|
|
|
|
Other comprehensive income (loss) |
1,746
|
1,742
|
|
|
|
1,742
|
4
|
Equity-based compensation expense |
2,642
|
2,642
|
|
2,642
|
|
|
|
Dividends declared on common stock and OP Units |
(51,124)
|
(50,964)
|
|
|
(50,964)
|
|
(160)
|
Net income |
51,676
|
51,517
|
|
|
51,517
|
|
159
|
Ending balance (in shares) at Jun. 30, 2024 |
|
|
175,330,314
|
|
|
|
|
Ending balance at Jun. 30, 2024 |
$ 3,252,271
|
3,243,798
|
$ 1,753
|
3,328,082
|
(111,373)
|
25,336
|
8,473
|
Beginning balance (in shares) at Dec. 31, 2024 |
187,537,592
|
|
187,537,592
|
|
|
|
|
Beginning balance at Dec. 31, 2024 |
$ 3,572,127
|
3,563,678
|
$ 1,875
|
3,658,219
|
(113,302)
|
16,886
|
8,449
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
Common stock issuance (in shares) |
|
|
9,732,006
|
|
|
|
|
Common stock issuance |
278,623
|
278,623
|
$ 97
|
278,526
|
|
|
|
Common stock withheld related to net share settlement of equity awards |
(6,300)
|
(6,300)
|
|
|
(6,300)
|
|
|
Costs related to issuance of common stock |
(443)
|
(443)
|
|
(443)
|
|
|
|
Other comprehensive income (loss) |
(22,364)
|
(22,295)
|
|
|
|
(22,295)
|
(69)
|
Equity based compensation expense (in shares) |
|
|
242,718
|
|
|
|
|
Equity-based compensation expense |
3,968
|
3,968
|
$ 2
|
3,966
|
|
|
|
Dividends declared on common stock and OP Units |
(58,655)
|
(58,368)
|
|
|
(58,368)
|
|
(287)
|
Net income |
56,281
|
56,108
|
|
|
56,108
|
|
173
|
Ending balance (in shares) at Mar. 31, 2025 |
|
|
197,512,316
|
|
|
|
|
Ending balance at Mar. 31, 2025 |
$ 3,823,237
|
3,814,971
|
$ 1,974
|
3,940,268
|
(121,862)
|
(5,409)
|
8,266
|
Beginning balance (in shares) at Dec. 31, 2024 |
187,537,592
|
|
187,537,592
|
|
|
|
|
Beginning balance at Dec. 31, 2024 |
$ 3,572,127
|
3,563,678
|
$ 1,875
|
3,658,219
|
(113,302)
|
16,886
|
8,449
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
Other comprehensive income (loss) |
(34,780)
|
|
|
|
|
|
|
Net income |
$ 119,651
|
|
|
|
|
|
|
Ending balance (in shares) at Jun. 30, 2025 |
198,138,567
|
|
198,138,567
|
|
|
|
|
Ending balance at Jun. 30, 2025 |
$ 3,837,986
|
3,829,888
|
$ 1,981
|
3,963,899
|
(118,201)
|
(17,791)
|
8,098
|
Beginning balance (in shares) at Mar. 31, 2025 |
|
|
197,512,316
|
|
|
|
|
Beginning balance at Mar. 31, 2025 |
3,823,237
|
3,814,971
|
$ 1,974
|
3,940,268
|
(121,862)
|
(5,409)
|
8,266
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
Common stock issuance (in shares) |
|
|
604,104
|
|
|
|
|
Common stock issuance |
20,186
|
20,186
|
$ 6
|
20,180
|
|
|
|
Common stock withheld related to net share settlement of equity awards |
(7)
|
(7)
|
|
|
(7)
|
|
|
Costs related to issuance of common stock |
(45)
|
(45)
|
|
(45)
|
|
|
|
Other comprehensive income (loss) |
(12,416)
|
(12,382)
|
|
|
|
(12,382)
|
(34)
|
Equity based compensation expense (in shares) |
|
|
22,147
|
|
|
|
|
Equity-based compensation expense |
3,497
|
3,497
|
$ 1
|
3,496
|
|
|
|
Dividends declared on common stock and OP Units |
(59,836)
|
(59,544)
|
|
|
(59,544)
|
|
(292)
|
Net income |
$ 63,370
|
63,212
|
|
|
63,212
|
|
158
|
Ending balance (in shares) at Jun. 30, 2025 |
198,138,567
|
|
198,138,567
|
|
|
|
|
Ending balance at Jun. 30, 2025 |
$ 3,837,986
|
$ 3,829,888
|
$ 1,981
|
$ 3,963,899
|
$ (118,201)
|
$ (17,791)
|
$ 8,098
|